Logo do repositório
 
Publicação

Impact of epigallocatechinn-3-gallate on Staphylococcus aureus molecular profile

2025-09Comunicação em conferência Acesso embargado
Ver registo simples
datacite.subject.sdg03:Saúde de Qualidade
dc.contributor.authorInácio, Raquel
dc.contributor.authorRibeiro, Edna
dc.contributor.authorCalado, Cecília R. C.
dc.date.accessioned2026-03-23T11:25:58Z
dc.date.available2026-03-23T11:25:58Z
dc.date.issued2025-09
dc.descriptionThis research was supported by the project grant IPL/IDICA2024/R-DICIP_ISEL supported by Instituto Politécnico de Lisboa. H&TRC authors acknowledge FCT/MCTES (UIDB/05608/2020 e UIDP/05608/2020) support.
dc.description.abstractThe discovery of new antimicrobial compounds is critical for the control of severe nosocomial infections, as those associated with methicillin-sensitive (MSSA) and resistant (MRSA) Staphylococcus aureus strains. In order to enhance new therapeutic approaches, it is crucial to develop new platforms to screen innovative compounds. Here, we evaluated how Fourier Transform Infra-Red (FTIR)-spectroscopy enables the prediction of antibiotic resistance and monitors the impact of epigallocatechin-3-gallate (EGCG) on the metabolism of MRSA and MSSA strains. Data showed that EGCG impacts the bacteria's metabolism, and that MRSA strains are more sensitive to EGCG. The high sensitivity of the technique also enabled us to discriminate the impact of EGCG concentrations, i.e., between 25 and 50, and between 50 and 100μg/ml. On the other hand, EGCG's impact on cellular molecular composition was lower than the differences between MSSA and MRSA strains. Furthermore, it was possible to predict these strains' resistance towards the antibiotics methicillin, amoxicillin, imipenem, and gentamicin. Since the spectra were acquired in a rapid, simple, economic, and high-throughput mode, this methodology may strongly promote the surveillance of nosocomial infection caused by S. aureus, and to screen new antimicrobial compounds.eng
dc.identifier.citationInácio R, Ribeiro E, Calado CR. Impact of epigallocatechinn-3-gallate on Staphylococcus aureus molecular profile. In: 8th IEEE Portuguese Meeting on Bioengineering – ENBENG 2025, Aveiro (Portugal), September 25-26, 2026.
dc.identifier.doi10.1109/enbeng67130.2025.11199611
dc.identifier.urihttp://hdl.handle.net/10400.21/22732
dc.language.isoeng
dc.peerreviewedyes
dc.publisherIEEE
dc.relation.hasversionhttps://ieeexplore.ieee.org/document/11199611
dc.relation.ispartof2025 IEEE 8th Portuguese Meeting on Bioengineering (ENBENG)
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectFCT_UIDP/05608/2020
dc.subjectFCT_UIDB/05608/2020
dc.subjectNosocomial infections
dc.subjectStaphylococcus aureus
dc.subjectFTIR-spectroscopy
dc.subjectEpigallocatechin-3-gallate
dc.titleImpact of epigallocatechinn-3-gallate on Staphylococcus aureus molecular profilepor
dc.typeconference paper
dspace.entity.typePublication
oaire.citation.conferenceDate2025-09
oaire.citation.conferencePlaceAveiro, Portugal
oaire.citation.title2025 IEEE 8th Portuguese Meeting on Bioengineering (ENBENG)
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNameRibeiro
person.givenNameEdna
person.identifier.ciencia-idC414-CDF2-D35A
person.identifier.orcid0000-0003-1316-7750
relation.isAuthorOfPublicationa571bf34-bcda-49ca-b5cb-4cdecbb3d9c7
relation.isAuthorOfPublication.latestForDiscoverya571bf34-bcda-49ca-b5cb-4cdecbb3d9c7

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Impact of epigallocatechinn-3-gallate on Staphylococcus aureus molecular profile.pdf
Tamanho:
510.88 KB
Formato:
Adobe Portable Document Format
Ver/Abrir
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
4.03 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Ver/Abrir

Coleções

ESTeSL - Artigos